WASHINGTON—US biotechnology companies Moderna Inc. and Pfizer Inc. said Monday they have started final-stage clinical trials of potential coronavirus vaccines each involving 30,000 participants.
The announcements come as the administration of US President Donald Trump is pouring massive investment into efforts to deliver millions of doses of a vaccine for the highly contagious virus by January next year, under what it calls “Operation Warp Speed.”
Read more.
You may also like these stories:
WHO Country Chief Urges Myanmar to Sustain ‘Amazing’ COVID-19 Response
Indonesia Eyes Final Stage of Clinical Tests of Vaccine in July